Asia Pacific API Intermediate Market Size, Share & Industry Trends Analysis Report By Type (Bulk Drug Intermediates, and Chemical Intermediates), By End User (Biotech & Pharmaceutical Companies, CMO), By Application, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific API Intermediate Market would witness market growth of 7.6% CAGR during the forecast period (2023-2030).

The increasing frequency of different diseases is one of the key factors driving the market. The most frequently prescribed synthetic medications are used to treat diabetes and hypertension. It significantly contributes to the disease burden in developed and developing countries as a risk factor for ischemic heart disease and stroke.

The indications above are significant risk factors for other diseases and syndromes, including ischaemic heart disease, glaucoma, and cancer. Pharmaceuticals that have been artificially created, such as metformin, atorvastatin, and enalapril, are frequently prescribed to treat the indications mentioned above. The rising prevalence of various diseases, including illnesses with a variety of etiologies, is therefore anticipated to fuel demand for pharmaceutical drugs for disease management, which in turn is expected to contribute to the demand for APIs, positively affecting the expansion of the market throughout the forecast period.

According to the International Diabetes Federation, more than 60% of those who have diabetes reside in Asia, with nearly half of them in China and India combined. According to WHO, China has one of the world's fastest-rising aging populations. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. The prevalence of diseases like diabetes, cancer, and others is anticipated to rise along with the aging population as they are predicted to be more susceptible to developing a variety of ailments. The market participants operating in the regional nations are expected to have significant growth opportunities due to all these factors.

The China market dominated the Asia Pacific API Intermediate Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $23.7 billion by 2030. The Japan market is anticipated to grow at a CAGR of 6.9% during (2023 - 2030). Additionally, The India market would register a CAGR of 8.3% during (2023 - 2030).

Based on Type, the market is segmented into Bulk Drug Intermediates, and Chemical Intermediates. Based on End User, the market is segmented into Biotech & Pharmaceutical Companies, CMO, and Others. Based on Application, the market is segmented into Analgesics, Antidiabetic Drugs, Anti-Infective Drugs, Cardiovascular Drugs, Anticancer Drugs, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide API Intermediate Market is Projected to reach USD 237.7 Billion by 2030, at a CAGR of 7.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cation Pharma, Espee Group, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla Limited, Cambrex Corporation, Vertellus, Dr. Reddy’s Laboratories Ltd., Evonik Industries AG (RAG-Stiftung), Pfizer, Inc., Shree Ganesh Remedies Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Bulk Drug Intermediates
• Chemical Intermediates

By End User

• Biotech & Pharmaceutical Companies
• CMO
• Others

By Application

• Analgesics
• Antidiabetic Drugs
• Anti-Infective Drugs
• Cardiovascular Drugs
• Anticancer Drugs
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Cation Pharma
• Espee Group
• Sandoo Pharmaceuticals and Chemicals Co., Ltd.
• Cipla Limited
• Cambrex Corporation
• Vertellus
• Dr.Reddy’s Laboratories Ltd.
• Evonik Industries AG (RAG-Stiftung)
• Pfizer, Inc.
• Shree Ganesh Remedies Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific API Intermediate Market, by Type
1.4.2 Asia Pacific API Intermediate Market, by End User
1.4.3 Asia Pacific API Intermediate Market, by Application
1.4.4 Asia Pacific API Intermediate Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis

Chapter 4. Strategies Deployed in API Intermediate Market

Chapter 5. Asia Pacific API Intermediate Market by Type
5.1 Asia Pacific Bulk Drug Intermediates Market by Country
5.2 Asia Pacific Chemical Intermediates Market by Country

Chapter 6. Asia Pacific API Intermediate Market by End User
6.1 Asia Pacific Biotech & Pharmaceutical Companies Market by Country
6.2 Asia Pacific CMO Market by Country
6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific API Intermediate Market by Application
7.1 Asia Pacific Analgesics Market by Country
7.2 Asia Pacific Antidiabetic Drugs Market by Country
7.3 Asia Pacific Anti-Infective Drugs Market by Country
7.4 Asia Pacific Cardiovascular Drugs Market by Country
7.5 Asia Pacific Anticancer Drugs Market by Country
7.6 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific API Intermediate Market by Country
8.1 China API Intermediate Market
8.1.1 China API Intermediate Market by Type
8.1.2 China API Intermediate Market by End User
8.1.3 China API Intermediate Market by Application
8.2 Japan API Intermediate Market
8.2.1 Japan API Intermediate Market by Type
8.2.2 Japan API Intermediate Market by End User
8.2.3 Japan API Intermediate Market by Application
8.3 India API Intermediate Market
8.3.1 India API Intermediate Market by Type
8.3.2 India API Intermediate Market by End User
8.3.3 India API Intermediate Market by Application
8.4 South Korea API Intermediate Market
8.4.1 South Korea API Intermediate Market by Type
8.4.2 South Korea API Intermediate Market by End User
8.4.3 South Korea API Intermediate Market by Application
8.5 Singapore API Intermediate Market
8.5.1 Singapore API Intermediate Market by Type
8.5.2 Singapore API Intermediate Market by End User
8.5.3 Singapore API Intermediate Market by Application
8.6 Malaysia API Intermediate Market
8.6.1 Malaysia API Intermediate Market by Type
8.6.2 Malaysia API Intermediate Market by End User
8.6.3 Malaysia API Intermediate Market by Application
8.7 Rest of Asia Pacific API Intermediate Market
8.7.1 Rest of Asia Pacific API Intermediate Market by Type
8.7.2 Rest of Asia Pacific API Intermediate Market by End User
8.7.3 Rest of Asia Pacific API Intermediate Market by Application

Chapter 9. Company Profiles
9.1 Cation Pharma
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Espee Group
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Trials and Approvals:
9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.4 Cipla Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Cambrex Corporation
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Acquisition and Mergers:
9.5.3 SWOT Analysis
9.6 Vertellus
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Dr. Reddy’s Laboratories Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Evonik Industries AG (RAG-Stiftung)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Geographical Expansions:
9.8.6 SWOT Analysis
9.9 Pfizer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional & Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Geographical Expansions:
9.9.6 SWOT Analysis
9.10. SHREE GANESH REMEDIES LIMITED
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 SWOT Analysis

TABLE 1 Asia Pacific API Intermediate Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific API Intermediate Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Bulk Drug Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Bulk Drug Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Chemical Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Chemical Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 10 Asia Pacific API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Biotech & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Biotech & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific CMO Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific CMO Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 18 Asia Pacific API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Analgesics Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Antidiabetic Drugs Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Antidiabetic Drugs Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Anti-Infective Drugs Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Anti-Infective Drugs Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Cardiovascular Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Cardiovascular Drugs Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Anticancer Drugs Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Anticancer Drugs Market by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 31 Asia Pacific API Intermediate Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific API Intermediate Market by Country, 2023 - 2030, USD Million
TABLE 33 China API Intermediate Market, 2019 - 2022, USD Million
TABLE 34 China API Intermediate Market, 2023 - 2030, USD Million
TABLE 35 China API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 36 China API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 37 China API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 38 China API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 39 China API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 40 China API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 41 Japan API Intermediate Market, 2019 - 2022, USD Million
TABLE 42 Japan API Intermediate Market, 2023 - 2030, USD Million
TABLE 43 Japan API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 44 Japan API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 45 Japan API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 46 Japan API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 47 Japan API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 48 Japan API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 49 India API Intermediate Market, 2019 - 2022, USD Million
TABLE 50 India API Intermediate Market, 2023 - 2030, USD Million
TABLE 51 India API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 52 India API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 53 India API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 54 India API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 55 India API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 56 India API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 57 South Korea API Intermediate Market, 2019 - 2022, USD Million
TABLE 58 South Korea API Intermediate Market, 2023 - 2030, USD Million
TABLE 59 South Korea API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 60 South Korea API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 61 South Korea API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 62 South Korea API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 63 South Korea API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 64 South Korea API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 65 Singapore API Intermediate Market, 2019 - 2022, USD Million
TABLE 66 Singapore API Intermediate Market, 2023 - 2030, USD Million
TABLE 67 Singapore API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 68 Singapore API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 69 Singapore API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 70 Singapore API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 71 Singapore API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 72 Singapore API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 73 Malaysia API Intermediate Market, 2019 - 2022, USD Million
TABLE 74 Malaysia API Intermediate Market, 2023 - 2030, USD Million
TABLE 75 Malaysia API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 76 Malaysia API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 77 Malaysia API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 78 Malaysia API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 79 Malaysia API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 80 Malaysia API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 81 Rest of Asia Pacific API Intermediate Market, 2019 - 2022, USD Million
TABLE 82 Rest of Asia Pacific API Intermediate Market, 2023 - 2030, USD Million
TABLE 83 Rest of Asia Pacific API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 84 Rest of Asia Pacific API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 85 Rest of Asia Pacific API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 86 Rest of Asia Pacific API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 87 Rest of Asia Pacific API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 88 Rest of Asia Pacific API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Cation Pharma
TABLE 90 Key Information – Espee Group
TABLE 91 Key Information – Sandoo Pharmaceuticals and Chemicals Co., Ltd.
TABLE 92 Key Information – Cipla Limited
TABLE 93 Key Information – Cambrex Corporation
TABLE 94 Key Information – Vertellus
TABLE 95 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 96 Key Information – Evonik Industries AG
TABLE 97 Key Information – Pfizer, Inc.
TABLE 98 Key Information – SHREE GANESH REMEDIES LIMITED

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific API Intermediate Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors API intermediate market
FIG 4 Porter’s Five Forces Analysis – API Intermediate Market
FIG 5 Asia Pacific API Intermediate Market share by Type, 2022
FIG 6 Asia Pacific API Intermediate Market share by Type, 2030
FIG 7 Asia Pacific API Intermediate Market by Type, 2019 - 2030, USD Million
FIG 8 Asia Pacific API Intermediate Market share by End User, 2022
FIG 9 Asia Pacific API Intermediate Market share by End User, 2030
FIG 10 Asia Pacific API Intermediate Market by End User, 2019 - 2030, USD Million
FIG 11 Asia Pacific API Intermediate Market share by Application, 2022
FIG 12 Asia Pacific API Intermediate Market share by Application, 2030
FIG 13 Asia Pacific API Intermediate Market by Application, 2019 - 2030, USD Million
FIG 14 Asia Pacific API Intermediate Market share by Country, 2022
FIG 15 Asia Pacific API Intermediate Market share by Country, 2030
FIG 16 Asia Pacific API Intermediate Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Cation Pharma
FIG 18 Swot Analysis: Sandoo Pharmaceuticals and Chemicals Co., Ltd.
FIG 19 SWOT Analysis: Cipla Limited
FIG 20 Swot Analysis: Cambrex Corporation
FIG 21 Swot Analysis: Vertellus
FIG 22 Swot Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 23 Recent strategies and developments: Evonik Industries AG
FIG 24 Swot Analysis: Evonik Industries AG
FIG 25 Swot Analysis: Pfizer, Inc.
FIG 26 Swot Analysis: SHREE GANESH REMEDIES LIMITED